Canavan Disease

This is a rare genetic disorder that affects the brain and nervous system. It causes the white matter in the brain to break down, leading to problems with movement, coordination, and learning. It usually starts in infancy and can cause severe disability.

Condition

What people with Canavan Disease report

Every report comes from a Lived member, sent anonymously.

Have you had Gastrostomy for Canavan Disease?

NameHow it went

About Canavan Disease

What It Is

Canavan disease is a rare inherited brain disorder that damages the white matter, the part of the brain made of nerve fibers wrapped in myelin, a fatty coating that lets signals travel quickly between nerve cells. As the white matter breaks down and develops a spongy appearance, the brain cannot send messages normally, and a child's development slows, stalls and then goes backward. It belongs to a group of genetic conditions called leukodystrophies. There are two main forms. The typical form, which affects most people with the condition, usually becomes noticeable at 3 to 5 months of age, after a baby has seemed well. Babies may have weak, floppy muscle tone (especially poor head control), a head that grows unusually large, irritability, and trouble feeding and swallowing. Later, muscles often become stiff, and vision, seizures and sleep can be affected. The atypical, milder form is less common. It usually shows up as delays in speech and movement in the first years of life, follows a more variable course, and can be so subtle that it is not recognized as Canavan disease for some time.

Causes & Risk Factors

Canavan disease is caused by changes (variants) in the ASPA gene, which carries the instructions for an enzyme called aspartoacylase. This enzyme normally breaks down a brain chemical called N-acetylaspartic acid (NAA). When the enzyme does not work, NAA builds up in the brain, and the imbalance interferes with forming and maintaining myelin. Variants that wipe out most enzyme activity tend to cause the typical form; variants that leave some activity tend to cause the milder form. Nothing a parent did during pregnancy or after birth causes it. The condition is inherited in an autosomal recessive pattern: a child is affected only when both copies of the gene carry a variant, one from each parent. Parents who each carry one copy are usually healthy and often have no family history. When both parents are carriers, each pregnancy has a 25% (one in four) chance of an affected child, a 50% chance of a child who is a healthy carrier, and a 25% chance of a child who neither has the condition nor carries it. Canavan disease occurs in people of every background but is more common in people of Ashkenazi (central and eastern European) Jewish heritage, which is why it is included in many carrier screening panels.

How It's Diagnosed

A doctor usually suspects Canavan disease when a baby misses early milestones such as head control and has a growing head size and unusual muscle tone. A brain MRI often shows widespread changes in the white matter, but similar pictures can come from other leukodystrophies, so the diagnosis rests on more specific tests. One is a urine test that measures NAA: a very high level points strongly to Canavan disease, although in the milder form it may be only slightly raised. A special MRI technique called proton magnetic resonance spectroscopy, which measures chemicals in the brain, can show the same buildup. Genetic testing that finds a disease-causing variant in both copies of the ASPA gene confirms the diagnosis, and doctors often run both kinds of test. Knowing the exact variants also lets relatives have carrier testing and lets parents consider testing in a future pregnancy, either before birth or on embryos during IVF (preimplantation genetic testing). An eye exam, hearing check and assessment of feeding and swallowing are often part of the first evaluation.

Treatment Options

There is no cure for Canavan disease and no treatment yet that stops the underlying damage. Care focuses on comfort, nutrition, function and quality of life, and it usually involves a team. A neurologist manages muscle stiffness (spasticity) and seizures if they occur, using medicines that relax muscles or prevent seizures. Physical and occupational therapists, along with orthopedic and rehabilitation specialists, work to prevent joints from becoming fixed in one position (contractures), support comfortable seating and positioning, and make the most of the abilities a child has. Feeding support is central. Swallowing problems can make eating slow and tiring and can let food or liquid go into the airway (aspiration), which can cause pneumonia. Feeding therapy, changes to food textures and, for many children, a feeding tube placed into the stomach help maintain nutrition and lower that risk. Children also benefit from educational services matched to their abilities, and palliative care teams can help with symptom relief and family support at any stage, not only near the end of life. Gene therapy is being tested in clinical trials, and lithium, a medicine best known as a mood stabilizer, has also been studied. These are not established treatments, and families who are interested can ask the care team whether a trial might be appropriate.

What to Expect

The course depends heavily on the form. In the typical form, children usually do not learn to sit, crawl or walk without support, and abilities that did develop may be lost as the disease progresses. Over time, many children have increasing muscle stiffness, vision loss, seizures, feeding difficulty and breathing problems. Life expectancy is reduced: most children with Canavan disease survive to about age 10, though this varies, and a smaller number live into adolescence or adulthood. The milder form tends to progress more slowly, and people with it often learn to speak and walk, although some lose skills later in childhood or adolescence. Daily life revolves around feeding, positioning, therapy and managing symptoms, and the care load on families is substantial. Regular follow-up tracks growth and nutrition, safety of eating by mouth, breathing, seizure control, development, mobility and equipment needs, and the family's need for respite or palliative support. Connecting with a leukodystrophy or rare disease center and with other families who have lived with the condition can help with both practical planning and emotional support.

When to Seek Help

See a doctor if a baby is not reaching early milestones such as holding up their head, seems unusually floppy, or has a head that is growing faster than expected. Adults with a family history of Canavan disease, or couples in which either partner has Ashkenazi Jewish heritage, can ask about carrier testing and genetic counseling before or early in a pregnancy. For a child already diagnosed, contact the care team promptly about coughing or choking during feeds, weight loss or poor intake, new or more frequent seizures, noisy breathing, or a noticeable loss of skills. Ask the neurologist for a written seizure plan that says what to do during a seizure and when it calls for emergency care. Call 911 if the child is struggling to breathe or has blue or gray lips, or has a seizure that lasts more than 5 minutes or does not stop as the seizure plan describes.

Questions to Ask Your Doctor

  1. 1.Which form of Canavan disease does my child appear to have, and what does that suggest about the course ahead?
  2. 2.How will we know if eating by mouth is becoming unsafe, and when would a feeding tube make sense?
  3. 3.Which specialists and therapies should be part of my child's care now, and how often should we be seen?
  4. 4.Are there clinical trials, such as gene therapy studies, that my child might be eligible for?
  5. 5.What do carrier testing and options for future pregnancies look like for our family and relatives?

Last reviewed • Oct 2026

Educational content, not medical advice.